doubled investment in 3 weeks
Id say NK has considerable upside yet. They are on the warp 14 list for covid 19 vaccine development, their serum base has already been tested safe in patients with compromised immunity in cancer trials. Their vaccine trials begin this month. Their proposed vaccine can be multipurposed as vaccine, booster and treatment. They have production availability to hit the required 100 million doses by Jan of 2021.